3 day Global Medical Conference begins in Chandigarh

Published On 2017-10-05 09:29 GMT   |   Update On 2017-10-05 09:29 GMT

Chandigarh: A three-day international conference, aimed at engaging industry and academic leaders to discuss current unmet medical needs, began at CSIR-Institute of Microbial Technology (IMTECH).CSIR-IMTECH is a premier microbial institute under the aegis of the Union Ministry of Science and Technology.The aim of the conference 'IMTechCon 2017' is to engage industry and academic leaders...

Login or Register to read the full article

Chandigarh: A three-day international conference, aimed at engaging industry and academic leaders to discuss current unmet medical needs, began at CSIR-Institute of Microbial Technology (IMTECH).


CSIR-IMTECH is a premier microbial institute under the aegis of the Union Ministry of Science and Technology.


The aim of the conference 'IMTechCon 2017' is to engage industry and academic leaders to discuss current unmet medical needs globally, IMTECH Director Anil Koul said.


The conference was presided over by Haryana Governor Kaptan Singh Solanki, who said that such close interactions will forge new R&D partnerships between industry and research institutions and lead to more product/technology development output.


"Partnerships between industry and academia have yielded great strides in research for IMTECH as has been witnessed by therapeutic use of clot buster Streptokinase for the public at large at affordable cost," the Governor added.

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News